Menorrhagia. Excessive and frequent menstruation with regular cycle
Conditions
Interventions
Intervention 1: Intervention Groups:Two mefenamic acid capsuls 250 mg every eight hours from first to third day of menstruation for two months and purslane capsule one hour after taking mefenamic aci
Treatment - Drugs
Intervention Groups:Two mefenamic acid capsuls 250 mg every eight hours from first to third day of menstruation for two months and purslane capsule one hour after taking mefenamic acid from first to
control Groups:Two mefenamic acid capsules 250 mg every eight hours from first to third day of menstruation for two months and placebo capsule one hour after taking mefenamic acid from first to third
Sponsors
Vice chancellor for research of School of Nursing and Midwifery of Shahid Beheshti University of Med
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria: being 18 to 40 years old; not having any pathologic problems and systematic diseases effective on hemorrhage like diabetes, coagulation disorders, hypo or hyperthyroidism, liver disorders or menstrual problems; not consuming any drugs effective on hemorrhage like aspirin, antidiabetics, antiepileptic, benzodiazepines, steroidal hormones or anticoagulants; not using hormonal contraceptive methods or IUDs; not having a history of abnormal pop smear or ultrasound (myoma, bicornuate uterus, endometrial hypertrophy, polyps, abnormal enlargement of the uterus); not being pregnant or intend to get pregnant during the next 3 months; not having diagnosed polycystic ovary syndrome; having a BMI withing the normal range
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of days of menstrual bleeding. Timepoint: Before intervention. The first menstrual cycle after the intervention. The second cycle of menstruation after intervention. Method of measurement: PBLAC Chart.;The volume of menstrual bleeding. Timepoint: Before intervention. The first menstrual cycle after the intervention. The second cycle of menstruation after intervention. Method of measurement: PBLAC Chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: The first menstrual cycle after intervention; second menstrual cycle after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGity Ozgoli
School of Nersing and Midwifery of Shahid Behesti University of Medical Sciences
Outcome results
None listed